Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Tevogen Bio Inc
< Previous
1
2
3
4
Next >
Tevogen Bio to Receive $8 Million of Non-Dilutive Grant Funding, Reiterates Efficient Operations
March 03, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
MSFT
TVGN
TVGNW
Tevogen Bio Founder and CEO Dr. Ryan Saadi Named to 2025 NJBIZ Power 100, Celebrating Innovation and Leadership in Accessible T Cell Therapy
February 28, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Bio’s First Trading Year Efficiency: 600% Higher Market Cap Per Team Member, 79% Insider-Owned
February 21, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Bio CEO Reinforces Commitment to Retention of Equity Capital and Long-Term Vision
February 14, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Bio Shares 2024 Financing Activity on One Year Anniversary of Becoming a Publicly Listed Company; Highlights Operational Efficiency
February 14, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Bio CEO Addresses Short Selling and Its Potential Impact on the Nation’s Health and Prosperity
February 14, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
MSFT
TVGN
TVGNW
Tevogen Bio CEO Congratulates RFK Jr. on His Confirmation as Secretary of the HHS; Echoes Commitment to Innovation and Affordability for Americans
February 13, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation
February 10, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Bio Meets BARDA TechWatch Team, Highlighting ExacTcell™ Technology’s Potential as a Scalable Medical Countermeasure
February 07, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Bio Enters Agreement to Receive Up To $10 Million of Non-Dilutive Grant Funding
January 28, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
MSFT
TVGN
TVGNW
Tevogen Bio CEO Congratulates Lynne Patton on Being Appointed Deputy Assistant to the President and Director of Minority Outreach
January 27, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Bio Broadens Relationship with Microsoft to Deepen Artificial Intelligence Collaboration and Develop PredicTcell Technology on Azure
January 24, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
MSFT
TVGN
TVGNW
Tevogen Bio to Host Panel Discussions “AI In Biopharma: Next Frontier of Medical Innovation” and “Pioneering the Economics of Health: Balancing Access and Outcomes” During J.P. Morgan Healthcare Conference
December 26, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Bio Highlights the Future of AI-Driven Drug Development in Fireside Chat with Microsoft During the J.P. Morgan Healthcare Conference
January 23, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
MSFT
TVGN
TVGNW
Tevogen Bio to Host Panel "AI In Biopharma: Next Frontier of Medical Innovation" During the 43rd Annual J.P. Morgan Healthcare Conference
December 23, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
MSFT
TVGN
TVGNW
Tevogen Bio Strengthens Robust IP Portfolio With Filing of Predictive AI Patent, With the Goal to Establish a Blueprint to Unlock the Full Potential of T Cell Therapies and Accelerate AI Integration to Advance Its Bold Growth Agenda
December 19, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
MSFT
TVGN
TVGNW
Tevogen Bio to Host Panel “Pioneering the Economics of Health: Balancing Access and Outcomes” During the 43rd Annual J.P. Morgan Healthcare Conference
December 17, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Bio to Attend the 43rd Annual J.P. Morgan Healthcare Conference
December 10, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Dr. Ryan Saadi Commends Individuals Who Dedicate Time to Public Service, and Congratulates Mayor Victor Sordillo on His Induction Into the NJ League of Municipalities Hall of Fame
December 05, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Bio Prepares Organizational Readiness to Support Company’s Growth Strategy
November 26, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Bio CEO Reflects on Public Support, Reaffirms Preserving Shareholder Value Remains His Priority, and Reinforces Options Including a Potential Share Buyback to Support Company Value
November 21, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Bio Reports Third Quarter 2024 Financial Results; Highlights Significantly Improved Financial Position, Unreported Asset Value on Balance Sheets, Efficient Business Model
November 19, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
UPDATE - Tevogen Founder Reflects on Importance of Preserving Shareholder Value While Navigating Growth as it Prepares to File Quarterly Financials
November 14, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Founder Reflects on Importance of Preserving Shareholder Value While Navigating Growth as it Prepares to File Quarterly Financials
November 14, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Bio Nears Finalization of Agreement to Enhance R&D and Manufacturing Capabilities; $36 Million Line of Credit Available for Continued Operations
November 08, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Bio CEO Dr. Ryan Saadi Expresses Gratitude for Prestigious ROI-NJ Recognition, Highlighting Company’s Novel Business Model as Key to Sustainable Success through Patient Affordability
November 05, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Bio Leverages Microsoft Partnership to Deliver Machine Learning Based Target Identification to Address Human Papilloma Virus (HPV), Advancing TVGN 920
November 05, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
MSFT
TVGN
TVGNW
Tevogen Bio Announces Appointment of Anthony Tarantino as Patient Advocate to Enhance Community Engagement and Patient Support
November 04, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Bio Expands on Microsoft Partnership to Integrate Machine Learning and AI into Preclinical Processes, Accelerating Drug Development and Reducing Costs
October 31, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
MSFT
TVGN
TVGNW
Tevogen Bio Reports Nasdaq Listing Compliance as CEO Reaffirms His Commitment in Bridging the Information Gap About the Company
October 29, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
MSFT
TVGN
TVGNW
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit